Loading…
Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression
Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of gastrointestinal mesenchymal development. Therefore, we...
Saved in:
Published in: | Oncotarget 2016-11, Vol.7 (48), p.78226-78241 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723 |
container_end_page | 78241 |
container_issue | 48 |
container_start_page | 78226 |
container_title | Oncotarget |
container_volume | 7 |
creator | Tang, Chih-Min Lee, Tracy E Syed, Sabriya A Burgoyne, Adam M Leonard, Stephanie Y Gao, Fei Chan, Jonathan C Shi, Eileen Chmielecki, Juliann Morosini, Deborah Wang, Kai Ross, Jeffrey S Kendrick, Michael L Bardsley, Michael R Siena, Martina De Mao, Junhao Harismendy, Olivier Ordog, Tamas Sicklick, Jason K |
description | Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of gastrointestinal mesenchymal development. Therefore, we hypothesized that Hedgehog signaling may be altered in human GIST and controls KIT expression. Quantitative RT-PCR, microarrays, and next generation sequencing were used to describe Hedgehog/PC-related genes in purified human ICC and GIST. Genetic and pharmacologic approaches were employed to investigate the effects of GLI manipulation on KIT expression and GIST cell viability. We report that Hedgehog pathway and PC components are expressed in ICC and GIST and subject to dysregulation during GIST oncogenesis, irrespective of KIT/PDGFRA mutation status. Using genomic profiling, 10.2% of 186 GIST studied had potentially deleterious genomic alterations in 5 Hedgehog-related genes analyzed, including in the PTCH1 tumor suppressor (1.6%). Expression of the predominantly repressive GLI isoform, GLI3, was inversely correlated with KIT mRNA levels in GIST cells and non-KIT/non-PDGFRA mutant GIST. Overexpression of the 83-kDa repressive form of GLI3 or small interfering RNA-mediated knockdown of the activating isoforms GLI1/2 reduced KIT mRNA. Treatment with GLI1/2 inhibitors, including arsenic trioxide, significantly increased GLI3 binding to the KIT promoter, decreased KIT expression, and reduced viability in imatinib-sensitive and imatinib-resistant GIST cells. These data offer new evidence that genes necessary for Hedgehog signaling and PC function in ICC are dysregulated in GIST. Hedgehog signaling activates KIT expression irrespective of mutation status, offering a novel approach to treat imatinib-resistant GIST. |
doi_str_mv | 10.18632/oncotarget.12909 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5346634</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1835683488</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723</originalsourceid><addsrcrecordid>eNpVUU1vEzEQtRCIVqU_gAvykcuW9bf3goQqaCMicSlna-J1do127WB7A_kh_F9MEkrxZeyZN2_e-CH0mrQ3REtG38VgY4E0uHJDaNd2z9Al6XjXUCHY8yf3C3Sd87e2HsGVpt1LdEGV6lhLxSX6de_6wY1xwDso4w844P6QkxuWCYqPAdsYSvKbpbiMS8RldEdgHFxw2Wcct3hcZgh4gFxS9KECiw8w4T_PucayzDFlvPeA79arZna9h-J6DLb4_WlIJfm8esDu5y65nGvmFXqxhSm763O8Ql8_fXy4vW_WX-5Wtx_WjWVClkZK1VMQDChIwSXte8u5JkRp6_SGcqY5qRnB-bmotBC0V61VVm4VZVfo_Yl3t2yqMOvqsjCZXfIzpIOJ4M3_leBHM8S9EYxLyXgleHsmSPH7Ulc3s8_WTRMEF5dsiK5CNeNaVyg5QW2KuX7x9nEMac3RUfPPUXN0tPa8earvseOvf-w3Mruj-g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835683488</pqid></control><display><type>article</type><title>Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression</title><source>PubMed Central</source><creator>Tang, Chih-Min ; Lee, Tracy E ; Syed, Sabriya A ; Burgoyne, Adam M ; Leonard, Stephanie Y ; Gao, Fei ; Chan, Jonathan C ; Shi, Eileen ; Chmielecki, Juliann ; Morosini, Deborah ; Wang, Kai ; Ross, Jeffrey S ; Kendrick, Michael L ; Bardsley, Michael R ; Siena, Martina De ; Mao, Junhao ; Harismendy, Olivier ; Ordog, Tamas ; Sicklick, Jason K</creator><creatorcontrib>Tang, Chih-Min ; Lee, Tracy E ; Syed, Sabriya A ; Burgoyne, Adam M ; Leonard, Stephanie Y ; Gao, Fei ; Chan, Jonathan C ; Shi, Eileen ; Chmielecki, Juliann ; Morosini, Deborah ; Wang, Kai ; Ross, Jeffrey S ; Kendrick, Michael L ; Bardsley, Michael R ; Siena, Martina De ; Mao, Junhao ; Harismendy, Olivier ; Ordog, Tamas ; Sicklick, Jason K</creatorcontrib><description>Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of gastrointestinal mesenchymal development. Therefore, we hypothesized that Hedgehog signaling may be altered in human GIST and controls KIT expression. Quantitative RT-PCR, microarrays, and next generation sequencing were used to describe Hedgehog/PC-related genes in purified human ICC and GIST. Genetic and pharmacologic approaches were employed to investigate the effects of GLI manipulation on KIT expression and GIST cell viability. We report that Hedgehog pathway and PC components are expressed in ICC and GIST and subject to dysregulation during GIST oncogenesis, irrespective of KIT/PDGFRA mutation status. Using genomic profiling, 10.2% of 186 GIST studied had potentially deleterious genomic alterations in 5 Hedgehog-related genes analyzed, including in the PTCH1 tumor suppressor (1.6%). Expression of the predominantly repressive GLI isoform, GLI3, was inversely correlated with KIT mRNA levels in GIST cells and non-KIT/non-PDGFRA mutant GIST. Overexpression of the 83-kDa repressive form of GLI3 or small interfering RNA-mediated knockdown of the activating isoforms GLI1/2 reduced KIT mRNA. Treatment with GLI1/2 inhibitors, including arsenic trioxide, significantly increased GLI3 binding to the KIT promoter, decreased KIT expression, and reduced viability in imatinib-sensitive and imatinib-resistant GIST cells. These data offer new evidence that genes necessary for Hedgehog signaling and PC function in ICC are dysregulated in GIST. Hedgehog signaling activates KIT expression irrespective of mutation status, offering a novel approach to treat imatinib-resistant GIST.</description><identifier>ISSN: 1949-2553</identifier><identifier>EISSN: 1949-2553</identifier><identifier>DOI: 10.18632/oncotarget.12909</identifier><identifier>PMID: 27793025</identifier><language>eng</language><publisher>United States: Impact Journals LLC</publisher><subject>Antineoplastic Agents - pharmacology ; Arsenicals - pharmacology ; Binding Sites ; Cell Line, Tumor ; Cell Survival ; Cilia - metabolism ; Cilia - pathology ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm ; Gastrointestinal Neoplasms - drug therapy ; Gastrointestinal Neoplasms - genetics ; Gastrointestinal Neoplasms - metabolism ; Gastrointestinal Neoplasms - pathology ; Gastrointestinal Stromal Tumors - drug therapy ; Gastrointestinal Stromal Tumors - genetics ; Gastrointestinal Stromal Tumors - metabolism ; Gastrointestinal Stromal Tumors - pathology ; Gene Expression Regulation, Neoplastic ; Humans ; Imatinib Mesylate - pharmacology ; Interstitial Cells of Cajal - drug effects ; Interstitial Cells of Cajal - metabolism ; Interstitial Cells of Cajal - pathology ; Mutation ; Nerve Tissue Proteins - genetics ; Nerve Tissue Proteins - metabolism ; Nuclear Proteins - antagonists & inhibitors ; Nuclear Proteins - genetics ; Nuclear Proteins - metabolism ; Oxides - pharmacology ; Priority Research Paper ; Promoter Regions, Genetic ; Proto-Oncogene Proteins c-kit - genetics ; Proto-Oncogene Proteins c-kit - metabolism ; Receptor, Platelet-Derived Growth Factor alpha - genetics ; RNA Interference ; RNA, Messenger - genetics ; RNA, Messenger - metabolism ; Signal Transduction - drug effects ; Transfection ; Zinc Finger Protein GLI1 - antagonists & inhibitors ; Zinc Finger Protein GLI1 - genetics ; Zinc Finger Protein GLI1 - metabolism ; Zinc Finger Protein Gli2 - antagonists & inhibitors ; Zinc Finger Protein Gli2 - genetics ; Zinc Finger Protein Gli2 - metabolism ; Zinc Finger Protein Gli3 - genetics ; Zinc Finger Protein Gli3 - metabolism</subject><ispartof>Oncotarget, 2016-11, Vol.7 (48), p.78226-78241</ispartof><rights>Copyright: © 2016 Tang et al. 2016</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723</citedby><cites>FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346634/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346634/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27793025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tang, Chih-Min</creatorcontrib><creatorcontrib>Lee, Tracy E</creatorcontrib><creatorcontrib>Syed, Sabriya A</creatorcontrib><creatorcontrib>Burgoyne, Adam M</creatorcontrib><creatorcontrib>Leonard, Stephanie Y</creatorcontrib><creatorcontrib>Gao, Fei</creatorcontrib><creatorcontrib>Chan, Jonathan C</creatorcontrib><creatorcontrib>Shi, Eileen</creatorcontrib><creatorcontrib>Chmielecki, Juliann</creatorcontrib><creatorcontrib>Morosini, Deborah</creatorcontrib><creatorcontrib>Wang, Kai</creatorcontrib><creatorcontrib>Ross, Jeffrey S</creatorcontrib><creatorcontrib>Kendrick, Michael L</creatorcontrib><creatorcontrib>Bardsley, Michael R</creatorcontrib><creatorcontrib>Siena, Martina De</creatorcontrib><creatorcontrib>Mao, Junhao</creatorcontrib><creatorcontrib>Harismendy, Olivier</creatorcontrib><creatorcontrib>Ordog, Tamas</creatorcontrib><creatorcontrib>Sicklick, Jason K</creatorcontrib><title>Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression</title><title>Oncotarget</title><addtitle>Oncotarget</addtitle><description>Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of gastrointestinal mesenchymal development. Therefore, we hypothesized that Hedgehog signaling may be altered in human GIST and controls KIT expression. Quantitative RT-PCR, microarrays, and next generation sequencing were used to describe Hedgehog/PC-related genes in purified human ICC and GIST. Genetic and pharmacologic approaches were employed to investigate the effects of GLI manipulation on KIT expression and GIST cell viability. We report that Hedgehog pathway and PC components are expressed in ICC and GIST and subject to dysregulation during GIST oncogenesis, irrespective of KIT/PDGFRA mutation status. Using genomic profiling, 10.2% of 186 GIST studied had potentially deleterious genomic alterations in 5 Hedgehog-related genes analyzed, including in the PTCH1 tumor suppressor (1.6%). Expression of the predominantly repressive GLI isoform, GLI3, was inversely correlated with KIT mRNA levels in GIST cells and non-KIT/non-PDGFRA mutant GIST. Overexpression of the 83-kDa repressive form of GLI3 or small interfering RNA-mediated knockdown of the activating isoforms GLI1/2 reduced KIT mRNA. Treatment with GLI1/2 inhibitors, including arsenic trioxide, significantly increased GLI3 binding to the KIT promoter, decreased KIT expression, and reduced viability in imatinib-sensitive and imatinib-resistant GIST cells. These data offer new evidence that genes necessary for Hedgehog signaling and PC function in ICC are dysregulated in GIST. Hedgehog signaling activates KIT expression irrespective of mutation status, offering a novel approach to treat imatinib-resistant GIST.</description><subject>Antineoplastic Agents - pharmacology</subject><subject>Arsenicals - pharmacology</subject><subject>Binding Sites</subject><subject>Cell Line, Tumor</subject><subject>Cell Survival</subject><subject>Cilia - metabolism</subject><subject>Cilia - pathology</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Neoplasm</subject><subject>Gastrointestinal Neoplasms - drug therapy</subject><subject>Gastrointestinal Neoplasms - genetics</subject><subject>Gastrointestinal Neoplasms - metabolism</subject><subject>Gastrointestinal Neoplasms - pathology</subject><subject>Gastrointestinal Stromal Tumors - drug therapy</subject><subject>Gastrointestinal Stromal Tumors - genetics</subject><subject>Gastrointestinal Stromal Tumors - metabolism</subject><subject>Gastrointestinal Stromal Tumors - pathology</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Imatinib Mesylate - pharmacology</subject><subject>Interstitial Cells of Cajal - drug effects</subject><subject>Interstitial Cells of Cajal - metabolism</subject><subject>Interstitial Cells of Cajal - pathology</subject><subject>Mutation</subject><subject>Nerve Tissue Proteins - genetics</subject><subject>Nerve Tissue Proteins - metabolism</subject><subject>Nuclear Proteins - antagonists & inhibitors</subject><subject>Nuclear Proteins - genetics</subject><subject>Nuclear Proteins - metabolism</subject><subject>Oxides - pharmacology</subject><subject>Priority Research Paper</subject><subject>Promoter Regions, Genetic</subject><subject>Proto-Oncogene Proteins c-kit - genetics</subject><subject>Proto-Oncogene Proteins c-kit - metabolism</subject><subject>Receptor, Platelet-Derived Growth Factor alpha - genetics</subject><subject>RNA Interference</subject><subject>RNA, Messenger - genetics</subject><subject>RNA, Messenger - metabolism</subject><subject>Signal Transduction - drug effects</subject><subject>Transfection</subject><subject>Zinc Finger Protein GLI1 - antagonists & inhibitors</subject><subject>Zinc Finger Protein GLI1 - genetics</subject><subject>Zinc Finger Protein GLI1 - metabolism</subject><subject>Zinc Finger Protein Gli2 - antagonists & inhibitors</subject><subject>Zinc Finger Protein Gli2 - genetics</subject><subject>Zinc Finger Protein Gli2 - metabolism</subject><subject>Zinc Finger Protein Gli3 - genetics</subject><subject>Zinc Finger Protein Gli3 - metabolism</subject><issn>1949-2553</issn><issn>1949-2553</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpVUU1vEzEQtRCIVqU_gAvykcuW9bf3goQqaCMicSlna-J1do127WB7A_kh_F9MEkrxZeyZN2_e-CH0mrQ3REtG38VgY4E0uHJDaNd2z9Al6XjXUCHY8yf3C3Sd87e2HsGVpt1LdEGV6lhLxSX6de_6wY1xwDso4w844P6QkxuWCYqPAdsYSvKbpbiMS8RldEdgHFxw2Wcct3hcZgh4gFxS9KECiw8w4T_PucayzDFlvPeA79arZna9h-J6DLb4_WlIJfm8esDu5y65nGvmFXqxhSm763O8Ql8_fXy4vW_WX-5Wtx_WjWVClkZK1VMQDChIwSXte8u5JkRp6_SGcqY5qRnB-bmotBC0V61VVm4VZVfo_Yl3t2yqMOvqsjCZXfIzpIOJ4M3_leBHM8S9EYxLyXgleHsmSPH7Ulc3s8_WTRMEF5dsiK5CNeNaVyg5QW2KuX7x9nEMac3RUfPPUXN0tPa8earvseOvf-w3Mruj-g</recordid><startdate>20161129</startdate><enddate>20161129</enddate><creator>Tang, Chih-Min</creator><creator>Lee, Tracy E</creator><creator>Syed, Sabriya A</creator><creator>Burgoyne, Adam M</creator><creator>Leonard, Stephanie Y</creator><creator>Gao, Fei</creator><creator>Chan, Jonathan C</creator><creator>Shi, Eileen</creator><creator>Chmielecki, Juliann</creator><creator>Morosini, Deborah</creator><creator>Wang, Kai</creator><creator>Ross, Jeffrey S</creator><creator>Kendrick, Michael L</creator><creator>Bardsley, Michael R</creator><creator>Siena, Martina De</creator><creator>Mao, Junhao</creator><creator>Harismendy, Olivier</creator><creator>Ordog, Tamas</creator><creator>Sicklick, Jason K</creator><general>Impact Journals LLC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161129</creationdate><title>Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression</title><author>Tang, Chih-Min ; Lee, Tracy E ; Syed, Sabriya A ; Burgoyne, Adam M ; Leonard, Stephanie Y ; Gao, Fei ; Chan, Jonathan C ; Shi, Eileen ; Chmielecki, Juliann ; Morosini, Deborah ; Wang, Kai ; Ross, Jeffrey S ; Kendrick, Michael L ; Bardsley, Michael R ; Siena, Martina De ; Mao, Junhao ; Harismendy, Olivier ; Ordog, Tamas ; Sicklick, Jason K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Antineoplastic Agents - pharmacology</topic><topic>Arsenicals - pharmacology</topic><topic>Binding Sites</topic><topic>Cell Line, Tumor</topic><topic>Cell Survival</topic><topic>Cilia - metabolism</topic><topic>Cilia - pathology</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Neoplasm</topic><topic>Gastrointestinal Neoplasms - drug therapy</topic><topic>Gastrointestinal Neoplasms - genetics</topic><topic>Gastrointestinal Neoplasms - metabolism</topic><topic>Gastrointestinal Neoplasms - pathology</topic><topic>Gastrointestinal Stromal Tumors - drug therapy</topic><topic>Gastrointestinal Stromal Tumors - genetics</topic><topic>Gastrointestinal Stromal Tumors - metabolism</topic><topic>Gastrointestinal Stromal Tumors - pathology</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Imatinib Mesylate - pharmacology</topic><topic>Interstitial Cells of Cajal - drug effects</topic><topic>Interstitial Cells of Cajal - metabolism</topic><topic>Interstitial Cells of Cajal - pathology</topic><topic>Mutation</topic><topic>Nerve Tissue Proteins - genetics</topic><topic>Nerve Tissue Proteins - metabolism</topic><topic>Nuclear Proteins - antagonists & inhibitors</topic><topic>Nuclear Proteins - genetics</topic><topic>Nuclear Proteins - metabolism</topic><topic>Oxides - pharmacology</topic><topic>Priority Research Paper</topic><topic>Promoter Regions, Genetic</topic><topic>Proto-Oncogene Proteins c-kit - genetics</topic><topic>Proto-Oncogene Proteins c-kit - metabolism</topic><topic>Receptor, Platelet-Derived Growth Factor alpha - genetics</topic><topic>RNA Interference</topic><topic>RNA, Messenger - genetics</topic><topic>RNA, Messenger - metabolism</topic><topic>Signal Transduction - drug effects</topic><topic>Transfection</topic><topic>Zinc Finger Protein GLI1 - antagonists & inhibitors</topic><topic>Zinc Finger Protein GLI1 - genetics</topic><topic>Zinc Finger Protein GLI1 - metabolism</topic><topic>Zinc Finger Protein Gli2 - antagonists & inhibitors</topic><topic>Zinc Finger Protein Gli2 - genetics</topic><topic>Zinc Finger Protein Gli2 - metabolism</topic><topic>Zinc Finger Protein Gli3 - genetics</topic><topic>Zinc Finger Protein Gli3 - metabolism</topic><toplevel>online_resources</toplevel><creatorcontrib>Tang, Chih-Min</creatorcontrib><creatorcontrib>Lee, Tracy E</creatorcontrib><creatorcontrib>Syed, Sabriya A</creatorcontrib><creatorcontrib>Burgoyne, Adam M</creatorcontrib><creatorcontrib>Leonard, Stephanie Y</creatorcontrib><creatorcontrib>Gao, Fei</creatorcontrib><creatorcontrib>Chan, Jonathan C</creatorcontrib><creatorcontrib>Shi, Eileen</creatorcontrib><creatorcontrib>Chmielecki, Juliann</creatorcontrib><creatorcontrib>Morosini, Deborah</creatorcontrib><creatorcontrib>Wang, Kai</creatorcontrib><creatorcontrib>Ross, Jeffrey S</creatorcontrib><creatorcontrib>Kendrick, Michael L</creatorcontrib><creatorcontrib>Bardsley, Michael R</creatorcontrib><creatorcontrib>Siena, Martina De</creatorcontrib><creatorcontrib>Mao, Junhao</creatorcontrib><creatorcontrib>Harismendy, Olivier</creatorcontrib><creatorcontrib>Ordog, Tamas</creatorcontrib><creatorcontrib>Sicklick, Jason K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncotarget</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tang, Chih-Min</au><au>Lee, Tracy E</au><au>Syed, Sabriya A</au><au>Burgoyne, Adam M</au><au>Leonard, Stephanie Y</au><au>Gao, Fei</au><au>Chan, Jonathan C</au><au>Shi, Eileen</au><au>Chmielecki, Juliann</au><au>Morosini, Deborah</au><au>Wang, Kai</au><au>Ross, Jeffrey S</au><au>Kendrick, Michael L</au><au>Bardsley, Michael R</au><au>Siena, Martina De</au><au>Mao, Junhao</au><au>Harismendy, Olivier</au><au>Ordog, Tamas</au><au>Sicklick, Jason K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression</atitle><jtitle>Oncotarget</jtitle><addtitle>Oncotarget</addtitle><date>2016-11-29</date><risdate>2016</risdate><volume>7</volume><issue>48</issue><spage>78226</spage><epage>78241</epage><pages>78226-78241</pages><issn>1949-2553</issn><eissn>1949-2553</eissn><abstract>Gastrointestinal stromal tumors (GIST) arise within the interstitial cell of Cajal (ICC) lineage due to activating KIT/PDGFRA mutations. Both ICC and GIST possess primary cilia (PC), which coordinate PDGFRA and Hedgehog signaling, regulators of gastrointestinal mesenchymal development. Therefore, we hypothesized that Hedgehog signaling may be altered in human GIST and controls KIT expression. Quantitative RT-PCR, microarrays, and next generation sequencing were used to describe Hedgehog/PC-related genes in purified human ICC and GIST. Genetic and pharmacologic approaches were employed to investigate the effects of GLI manipulation on KIT expression and GIST cell viability. We report that Hedgehog pathway and PC components are expressed in ICC and GIST and subject to dysregulation during GIST oncogenesis, irrespective of KIT/PDGFRA mutation status. Using genomic profiling, 10.2% of 186 GIST studied had potentially deleterious genomic alterations in 5 Hedgehog-related genes analyzed, including in the PTCH1 tumor suppressor (1.6%). Expression of the predominantly repressive GLI isoform, GLI3, was inversely correlated with KIT mRNA levels in GIST cells and non-KIT/non-PDGFRA mutant GIST. Overexpression of the 83-kDa repressive form of GLI3 or small interfering RNA-mediated knockdown of the activating isoforms GLI1/2 reduced KIT mRNA. Treatment with GLI1/2 inhibitors, including arsenic trioxide, significantly increased GLI3 binding to the KIT promoter, decreased KIT expression, and reduced viability in imatinib-sensitive and imatinib-resistant GIST cells. These data offer new evidence that genes necessary for Hedgehog signaling and PC function in ICC are dysregulated in GIST. Hedgehog signaling activates KIT expression irrespective of mutation status, offering a novel approach to treat imatinib-resistant GIST.</abstract><cop>United States</cop><pub>Impact Journals LLC</pub><pmid>27793025</pmid><doi>10.18632/oncotarget.12909</doi><tpages>16</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1949-2553 |
ispartof | Oncotarget, 2016-11, Vol.7 (48), p.78226-78241 |
issn | 1949-2553 1949-2553 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5346634 |
source | PubMed Central |
subjects | Antineoplastic Agents - pharmacology Arsenicals - pharmacology Binding Sites Cell Line, Tumor Cell Survival Cilia - metabolism Cilia - pathology Dose-Response Relationship, Drug Drug Resistance, Neoplasm Gastrointestinal Neoplasms - drug therapy Gastrointestinal Neoplasms - genetics Gastrointestinal Neoplasms - metabolism Gastrointestinal Neoplasms - pathology Gastrointestinal Stromal Tumors - drug therapy Gastrointestinal Stromal Tumors - genetics Gastrointestinal Stromal Tumors - metabolism Gastrointestinal Stromal Tumors - pathology Gene Expression Regulation, Neoplastic Humans Imatinib Mesylate - pharmacology Interstitial Cells of Cajal - drug effects Interstitial Cells of Cajal - metabolism Interstitial Cells of Cajal - pathology Mutation Nerve Tissue Proteins - genetics Nerve Tissue Proteins - metabolism Nuclear Proteins - antagonists & inhibitors Nuclear Proteins - genetics Nuclear Proteins - metabolism Oxides - pharmacology Priority Research Paper Promoter Regions, Genetic Proto-Oncogene Proteins c-kit - genetics Proto-Oncogene Proteins c-kit - metabolism Receptor, Platelet-Derived Growth Factor alpha - genetics RNA Interference RNA, Messenger - genetics RNA, Messenger - metabolism Signal Transduction - drug effects Transfection Zinc Finger Protein GLI1 - antagonists & inhibitors Zinc Finger Protein GLI1 - genetics Zinc Finger Protein GLI1 - metabolism Zinc Finger Protein Gli2 - antagonists & inhibitors Zinc Finger Protein Gli2 - genetics Zinc Finger Protein Gli2 - metabolism Zinc Finger Protein Gli3 - genetics Zinc Finger Protein Gli3 - metabolism |
title | Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A17%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hedgehog%20pathway%20dysregulation%20contributes%20to%20the%20pathogenesis%20of%20human%20gastrointestinal%20stromal%20tumors%20via%20GLI-mediated%20activation%20of%20KIT%20expression&rft.jtitle=Oncotarget&rft.au=Tang,%20Chih-Min&rft.date=2016-11-29&rft.volume=7&rft.issue=48&rft.spage=78226&rft.epage=78241&rft.pages=78226-78241&rft.issn=1949-2553&rft.eissn=1949-2553&rft_id=info:doi/10.18632/oncotarget.12909&rft_dat=%3Cproquest_pubme%3E1835683488%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-667d2a53a2a65462ddc4481178ce8b243841c44544462ddc478552d70c7c6f723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1835683488&rft_id=info:pmid/27793025&rfr_iscdi=true |